OTC Pharmaceuticals - Bangladesh

  • Bangladesh
  • Revenue in the OTC Pharmaceuticals market amounts to US$1,537.00m in 2024. The market is expected to grow annually by 13.91% (CAGR 2024-2029).
  • The market's largest segment is the segment Vitamins & Minerals with a market volume of US$571.40m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$8.80 are generated in 2024.
  • In the OTC Pharmaceuticals market, 0.4% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Bangladesh is experiencing significant growth and development.

Customer preferences:
Bangladesh is a densely populated country with a growing middle class and an increasing awareness of health and wellness. As a result, there is a growing demand for over-the-counter (OTC) pharmaceutical products. Consumers in Bangladesh are increasingly looking for convenient and accessible healthcare solutions, and OTC medications provide them with the opportunity to self-treat common ailments without the need for a prescription.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in Bangladesh is the increasing availability and variety of OTC products. Pharmaceutical companies are expanding their product portfolios to cater to the specific needs of the Bangladeshi market. This includes the introduction of new OTC medications for common ailments such as cough, cold, and allergies, as well as products for pain relief and digestive health. The market is also witnessing the rise of herbal and natural OTC products, as consumers are becoming more interested in alternative and traditional remedies. Another trend in the market is the growing popularity of online pharmacies and e-commerce platforms. With the increasing penetration of smartphones and internet connectivity, consumers in Bangladesh are embracing the convenience of online shopping for their healthcare needs. Online pharmacies offer a wide range of OTC medications and provide doorstep delivery, making it easier for consumers to access the products they need.

Local special circumstances:
Bangladesh has a well-established pharmaceutical industry, with several local manufacturers producing high-quality generic medications. This has contributed to the availability and affordability of OTC products in the country. Local manufacturers are also investing in research and development to introduce new and innovative OTC medications to the market.

Underlying macroeconomic factors:
The OTC Pharmaceuticals market in Bangladesh is benefiting from several macroeconomic factors. The country has been experiencing steady economic growth, which has resulted in an increase in disposable income and consumer spending. This, coupled with the growing middle class and changing lifestyles, has led to an increased demand for healthcare products, including OTC medications. Furthermore, the government of Bangladesh has been actively promoting the development of the pharmaceutical industry. This includes providing incentives to local manufacturers, improving regulatory frameworks, and encouraging investments in research and development. These initiatives have created a favorable environment for the growth of the OTC Pharmaceuticals market in the country. In conclusion, the OTC Pharmaceuticals market in Bangladesh is witnessing significant growth and development. Customer preferences for convenient and accessible healthcare solutions, coupled with the availability of a wide range of OTC products, are driving the market. The rise of online pharmacies and e-commerce platforms is also contributing to the growth. Local special circumstances, such as the presence of a well-established pharmaceutical industry and government support, further support the market's development. The underlying macroeconomic factors, including economic growth and government initiatives, are also fueling the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)